Author:
Blazeska Nina,Kosaloglu-Yalcin Zeynep,Vita Randi,Peters Bjoern,Sette Alessandro
Reference50 articles.
1. Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, Wheeler DK, Sette A, Peters B (2019) The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res 47(D1):D339–D343. https://doi.org/10.1093/nar/gky1006
2. Lloyd KO, Old LJ (1989) Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients. Cancer Res 49(13):3445–3451
3. Boon T, De Plaen E, Lurquin C, Van den Eynde B, van der Bruggen P, Traversari C, Amar-Costesec A, Van Pel A (1992) Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surv 13:23–37
4. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61–89. https://doi.org/10.1111/j.1600-065x.1995.tb00077.x
5. Slingluff CL Jr, Hunt DF, Engelhard VH (1994) Direct analysis of tumor-associated peptide antigens. Curr Opin Immunol 6(5):733–740. https://doi.org/10.1016/0952-7915(94)90077-9